Surgical Hemostats Market Trends

Growth Drivers

Burgeoning aging population- Elderly individuals often require surgical interventions for various health conditions, ranging from cardiovascular issues to orthopedic procedures. The prevalence of age-related ailments necessitating surgical treatment amplifies the demand for reliable hemostatic solutions. As healthcare systems adapt to address the needs of an aging demographic, the market for surgical hemostats is poised to witness sustained growth, aligning with the rising demand for surgical procedures among the elderly. According to the World Health Organization (WHO), the number of individuals 60 years of age and over will reach 2.1 billion worldwide by 2050.
Increasing prevalence of chronic diseases- Conditions such as cardiovascular disorders often require intricate surgical procedures where effective hemostasis is paramount. The incidence of chronic illnesses, coupled with advancements in medical diagnostics, leads to the identification of more cases necessitating surgical management.
Growing number of road accidents- An increase in traffic accidents has resulted in a spike in surgical procedures, which necessitates the usage of surgical hemostats since it is essential for emergencies in hospital settings. As per statistics, globally there were more than 11% more traffic accidents in 2022 than there were in 2021.

Challenges

Exorbitant cost and need for skilled professionals - The high cost of hemostasis products is a result of the use of cutting-edge technology and the cost associated with acquiring qualified personnel may restrict the industry growth, particularly in areas with limited resources.
Risk of adverse complications can impact the market adoption of surgical hemostats- Despite being rare, there have been reports of potentially fatal side effects and complications with the use of resorbable hemostatic materials, such as gel foam, microfibrillar collagen, resorbable collagen since they run the risk of adhering to tissue and becoming infected, particularly if any portion of them is left unabsorbed.
Regulatory compliance may cause approval delays and may impede industry expansion

Surgical Hemostats Market: Key Insights

Base Year	2024
Forecast Year	2025-2037
CAGR	5.5%
Base Year Market Size (2024)	USD 3.56 billion
Forecast Year Market Size (2037)	USD 7.14 billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of surgical hemostats is evaluated at USD 3.72 billion.

The surgical hemostats market size was over USD 3.56 billion in 2024 and is poised to exceed USD 7.14 billion by 2037, witnessing over 5.5% CAGR during the forecast period i.e., between 2025-2037. The escalating number of surgical procedures worldwide stands out as the primary catalyst, propelling the market growth.

North America industry is poised to dominate majority revenue share of 35% by 2037, due to rising spending on healthcare in the region.

The major players in the market include Ethicon, Inc., Baxter International Inc., Medtronic plc, B. Braun Melsungen AG, Pfizer Inc., CryoLife, Inc., C.R. Bard, Inc., Integra LifeSciences Corporation, Z-Medica, LLC, Cardinal Health, Inc.

Surgical Hemostats Market Trends